Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas

Clinical Neurology and Neurosurgery

Volumn 111, Issue 2, 2009, Pages 127-133

  Hirota, Yuichi ^a   Tachibana, Osamu ^b   Uchiyama, Naoyuki ^a   Hayashi, Yasuhiko ^a   Nakada, Mitsutoshi ^a   Kita, Daisuke ^a   Watanabe, Takuya ^a   Higashi, Ryo ^a   Hamada, Jun ichiro ^a   Hayashi, Yutaka ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Estrogen receptor (ER); Gonadotropin releasing hormone (GnRH); Gonadotropin releasing hormone receptor (GnRH R); Meningiomas; Progesterone receptor (PR)

Indexed keywords

ESTROGEN RECEPTOR; GONADORELIN; GONADORELIN RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, LHRH; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; YOUNG ADULT;

EID: 58349107439     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.09.015     Document Type: Article

References (32)

1. Perry A., Louis D.N., Scheithauer B.W., Budka H., and von Deimling A. Meningiomas. In: Louis D.N., Ohgaki H., Wiestler O.D., and Cavenee W.K. (Eds). WHO classification of tumours of the central nervous system (2007), International Agency for Research on Cancer (IARC), Lyon 164-172
2. Goldsmith B.J., Wara W.M., Wilson C.B., and Larson D.A. Postoperative irradiation for subtotally resected meningiomas: a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80 (1994) 195-201
3. Mirabell R., Linggood R.M., de la Monte S., Convery K., Munzenrider J.E., and Mirimanoff R.O. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13 (1992) 157-164
4. Russell D.S., and Rubenstein L.J. Pathology of tumors of the central nervous system. 5th ed. (1989), Williams & Wilkins, Baltimore p. 452-453
5. Bickerstaff E.R., Small J.M., and Guest I.A. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21 (1958) 89-91
6. Miller R.E. Breast cancer and meningioma. J Surg Oncol 31 (1986) 182-183
7. Schoenberg B.S., Christine B.W., and Whisnant J.P. Nervous system neoplasms and primary malignancies of other sites: the unique association between meningiomas and breast cancer. Neurology 25 (1975) 705-712
8. Michelsen J.J., and New P.F.J. Brain tumor and pregnancy. J Neurol Neurosurg Psychiatry 32 (1969) 305-307
9. Blankenstein M.A., Berns P.M., Blaauw G., Mulder E., and Thijssen J.H. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor. Cancer Res 46 (1986) 4268-4270
10. Brandis A., Mirzai S., Tatagiba M., Walter G.F., Samii M., and Ostertag H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33 (1993) 212-217
11. Cahill D.W., Bashirelahi N., Solomon L.W., Dalton T., Salcman M., and Ducker T.B. Estrogen and progesterone receptors in meningiomas. J Neurosurg 60 (1984) 985-993
12. Carroll R.S., Glowacka D., Dashner K., and Black P.M. Progesterone receptor expression in meningiomas. Cancer Res 53 (1993) 1312-1316
13. Donnell M.S., Meyer G.A., and Donegan W.L. Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50 (1979) 499-502
14. Halper J., Colvard D.S., Scheithauer B.W., Jiang N.S., Press M.F., Graham M.L.J., et al. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Neurosurgery 25 (1989) 546-552
15. Lesch K.P., and Gross S. Estrogen receptor immunoreactivity in meningiomas: comparison with the binding activity of estrogen, progesterone, and androgen receptors. J Neurosurg 67 (1987) 237-243
16. Schrell U.M., Adams E.F., Fahlbusch R., Greb R., Jirikowski G., Prior R., et al. Hormonal dependency of cerebral meningiomas. Part 1. Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73 (1990) 743-749
17. Hsu D.W., Efird J.T., and Hedley-Whyte E.T. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86 (1997) 113-120
18. Markwalder T.M., Zava D.T., Goldhirsch A., and Markwalder R.V. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol 20 (1983) 42-47
19. Perrot-Applanat M., Groyer-Picard M.T., and Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir (Wien) 115 (1992) 20-30
20. Bowen R.L., and Atwood C.S. Living and dying for sex: a theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 50 (2004) 265-290
21. Maxwell M., Galanopoulos T., Neville-Golden J., and Antoniades H.N. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78 (1993) 456-462
22. van Groeninghen J.C., Kiesel L., Winkler D., and Zwirner M. Effects of luteinising-hormone-releasing hormone on nervous-system tumours. Lancet 352 (1998) 372-373
23. Ironside J.W., Battersby R.D., Dangerfield V.J., Parsons M.A., Timperley W.R., and Underwood J.C. Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol 39 (1986) 44-50
24. Matsuda Y., Kawamoto K., Kiya K., Kurisu K., Sugiyama K., and Uozumi T. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80 (1994) 527-534
25. Nagashima G., Aoyagi M., Wakimoto H., Tamaki M., Ohno K., and Hirakawa K. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37 (1995) 478-482
26. Horwitz K.B., and Alexander P.S. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113 (1983) 2195-2201
27. Tung L., Mohamed M.K., Hoeffler J.P., Takimoto G.S., and Horwitz K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7 (1993) 1256-1265
28. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., and McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7 (1993) 1244-1255
29. Millar R.P., Pawson A.J., Morgan K., Rissman E., and Lu Z.-L. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front Neuroendocrinol 29 (2008) 17-35
30. Imai A., Ohno T., Iida K., Fuseya T., Furui T., and Tamaya T. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol 55 (1994) 144-148
31. Kang S.K., Cheng K.W., Nathwani P.S., Choi K.C., and Leung P.C. Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth. Endocrine 13 (2000) 297-304
32. Miller W.R., Scott W.N., Morris R., Fraser H.M., and Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313 (1985) 231-233